Aviva invests in technology that detects early signs of cancer

Aviva Ventures, the VC arm of Aviva responsible for investing in exciting tech, announced its investment in Owlstone Medical, which develops a cancer breathalyzer that analyzes chemicals in one’s breath to detect cancer in its early stages when it’s treatable. ‘In the business of saving lives’ just took on a whole new meaning. Bottom Line: (1) great tech, (2) a great team, and (3) a strategic alignment – aka the stuff Aviva Ventures looks for. Recall Aviva’s investments below.

Speaking of Cocoon, the UK-based smart home security system provider, announced it has raised £2.46 million in equity crowdfunding on Crowdcube. The 3-year-old startup has secured $7.19 million since inception and has attracted the attention of Zurich. Look below. Either way, smells fishy.


BTW, did you know that Travelers partnered with CNET thinking a full page on home automation tips is a good idea?